Patents Assigned to Dendreon Pharmaceuticals LLC
  • Patent number: 11970743
    Abstract: Gene expression profiling in patients with mCRPC identifying genes that predict overall survival in response to treatment with sipuleucel-T, the method comprising the steps of (a) determining a gene expression level of a first biomarker; (b) determining a gene expression level of at least one additional biomarker different from the first biomarker; and (c) transforming the expression level of the first biomarker and the at least one additional biomarker into a first score corresponding to a probability of overall survival in response to treatment with sipuleucel-T.
    Type: Grant
    Filed: September 9, 2019
    Date of Patent: April 30, 2024
    Assignee: Dendreon Pharmaceuticals LLC
    Inventors: James B. Trager, Nadeem A. Sheikh, Debraj GuhaThakurta, Harini Kandadi, Li-Qun Fan